The Latest Breaking News from Eli Lilly

When Mounjaro came on the market, TikTok went wild. People with obesity ordered the drug in droves thanks to a coupon that allowed them to access it for just $25 a month. Then the coupon went away, leaving destruction in its wake — and obese patients warring with diabetics. Emily…

Hannah Crabtree got active on Twitter in 2016 to find more people like herself: those with Type 1 diabetes who’d hacked their insulin pumps to automatically adjust the amount of insulin delivered.

"Over the course of this critical year, we hope to launch as many as four new medicines for challenging diseases, while advancing our next generation of molecules currently in Phase 3." said CEO David Ricks.

CNBC's Jim Cramer has a lot to say about Wegovy, Novo Nordisk's fast-selling weight loss treatment.

NHS crisis, withdrawal of tax credits and exit from EU blamed for fall in UK share of R&D market

Eli Lilly stock dipped Friday after the FDA unexpectedly rejected its request for an accelerated approval of its Alzheimer's treatment.

Eli Lilly shares slipped Friday morning after regulators said they need to see more data on the company’s application for a quick approval of its potential Alzheimer’s disease treatment

"We are committed to working with the FDA to ensure the fastest possible path to bring this potential medicine to patients in need," Eli Lilly said.

Stock futures mixed with Fed talk, earnings in focus; Netflix surges as blowout subscriber gains offset earnings miss; Costco shares gain as bulk retail unveils $4 billion buyback plan; Nordstrom slumps after slashing profit forecast following weak holiday sales and Eli Lilly slides as FDA rejects fast track review of…